ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Oxford Cancer Biomarkers Limited

Oxford Cancer Biomarkers Limited is an active company incorporated on 24 May 2010 with the registered office located in Kilmacolm, Renfrewshire. Oxford Cancer Biomarkers Limited was registered 15 years ago.
Status
Active
Active since 13 years ago
Company No
SC379069
Private limited company
Scottish Company
Age
15 years
Incorporated 24 May 2010
Size
Micro
Turnover is under £1M
Balance sheet is under £500,000
Under 10 employees
Confirmation
Submitted
Dated 23 December 2024 (10 months ago)
Next confirmation dated 23 December 2025
Due by 6 January 2026 (1 month remaining)
Last change occurred 10 months ago
Accounts
Submitted
For period 1 Jan31 Dec 2024 (1 year)
Accounts type is Total Exemption Full
Next accounts for period 31 December 2025
Due by 30 September 2026 (10 months remaining)
Address
C/O Douglas Mcdonald Ca
2 Octavia Buildings
Kilmacolm
PA13 4AE
Same address since incorporation
Telephone
01865784743
Email
Unreported
People
Officers
4
Shareholders
21
Controllers (PSC)
1
Director • British • Lives in UK • Born in Nov 1957
Director • British • Lives in England • Born in Jun 1956
Director • British • Lives in England • Born in Jan 1980
Director • South Korean • Lives in South Korea • Born in Apr 1960
PSC
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Celleron Therapeutics Limited
Prof Nicholas Barrie La Thangue is a mutual person.
Active
MJ & Family UK Limited
Mohammed Jamal is a mutual person.
Active
Argonaut Therapeutics Limited
Prof Nicholas Barrie La Thangue is a mutual person.
Active
MJF Friendlyscore SPV Limited
Mohammed Jamal is a mutual person.
Active
SSF SPV Limited
Mohammed Jamal is a mutual person.
Active
Exen Capital Advisors Ltd
Mohammed Jamal is a mutual person.
Active
MJ Family Group Ltd
Mohammed Jamal is a mutual person.
Active
Double I Delices Ltd
Mohammed Jamal is a mutual person.
Active
Brands
Oxford Cancer Biomarkers
Oxford Cancer Biomarkers develops cancer biomarker technology to support clinical decision-making.
Financials
Net Assets, Total Assets & Total Liabilities (2015–2024)
Period Ended
31 Dec 2024
For period 31 Dec31 Dec 2024
Traded for 12 months
Cash in Bank
£31K
Decreased by £107K (-78%)
Turnover
Unreported
Same as previous period
Employees
2
Decreased by 6 (-75%)
Total Assets
£376K
Decreased by £147K (-28%)
Total Liabilities
-£374K
Decreased by £186K (-33%)
Net Assets
£2K
Increased by £39K (-105%)
Debt Ratio (%)
99%
Decreased by 7.61% (-7%)
Latest Activity
Full Accounts Submitted
8 Months Ago on 11 Mar 2025
Confirmation Submitted
10 Months Ago on 2 Jan 2025
Full Accounts Submitted
1 Year 4 Months Ago on 26 Jun 2024
Kyoung Mee Lee Resigned
1 Year 6 Months Ago on 23 Apr 2024
Professor David James Kerr Appointed
1 Year 6 Months Ago on 17 Apr 2024
Full Accounts Submitted
1 Year 9 Months Ago on 6 Feb 2024
Confirmation Submitted
1 Year 10 Months Ago on 2 Jan 2024
Dean Marc Slagel Resigned
1 Year 11 Months Ago on 22 Nov 2023
Joanna Smart Resigned
2 Years 1 Month Ago on 13 Sep 2023
Christopher Malcolm Towler Resigned
2 Years 5 Months Ago on 16 May 2023
Get Credit Report
Discover Oxford Cancer Biomarkers Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Total exemption full accounts made up to 31 December 2024
Submitted on 11 Mar 2025
Confirmation statement made on 23 December 2024 with updates
Submitted on 2 Jan 2025
Statement of capital following an allotment of shares on 3 June 2024
Submitted on 28 Jun 2024
Statement of capital following an allotment of shares on 3 June 2024
Submitted on 27 Jun 2024
Total exemption full accounts made up to 31 December 2023
Submitted on 26 Jun 2024
Termination of appointment of Kyoung Mee Lee as a director on 23 April 2024
Submitted on 23 Apr 2024
Appointment of Professor David James Kerr as a director on 17 April 2024
Submitted on 18 Apr 2024
Resolutions
Submitted on 26 Mar 2024
Total exemption full accounts made up to 31 December 2022
Submitted on 6 Feb 2024
Confirmation statement made on 23 December 2023 with updates
Submitted on 2 Jan 2024
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year